Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Mullol, Joaquim" or (type any "bookEditor journalEditor issueEditor" and editor="Mullol, ...

Add to list
- Journal Article
- A1
Dupilumab improves health-related quality of life in severe chronic rhinosinusitis with nasal polyps

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui and Asif H. Khan (UGent)

(2023) ALLERGY.
Add to list
- Journal Article
- A1
- open access
Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui, Chien Chia Chuang, et al.

(2022) ALLERGY. 77(7). p.2211-2221
Add to list
- Journal Article
- A1
- open access
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

Philippe Gevaert (UGent) , Rebecca Saenz, Jonathan Corren, Joseph K. Han, Joaquim Mullol, Stella E. Lee, Randall A. Ow, Rui Zhao, Monet Howard, Kit Wong, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(3). p.957-965.e3
Add to list
- Journal Article
- A1
- open access
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert (UGent) , Leda P. Mannent, G. Walter Canonica, Joseph K. Han, Jorge F. Maspero, Cesar Picado, Nadia Daizadeh, Benjamin Ortiz, et al.

(2022) ALLERGY. 77(4). p.1231-1244
Add to list
- Conference Paper
- C3
Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

Andrew Lane, Joaquim Mullol, Claire Hopkins, Wytske Fokkens, Stella Lee, Asif H. Khan (UGent) , Jérôme Msihid, Scott Nash, Shahid Siddiqui, Urvi Mujumdar, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB144-AB144
Add to list
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Joaquim Mullol, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter W Hellings, Joseph K Han, Roger Jankowski, Jan Vodicka, Philippe Gevaert (UGent) , Nadia Daizadeh, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(4). p.1086-1095.e5
Add to list
Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply

Philippe Gevaert (UGent) , Jonathan Corren, Joaquim Mullol, Joseph Han, Stella E. Lee, Monica Ligueros-Saylan, Kit Wong, Theodore A. Omachi and Claus Bachert (UGent)

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(1). p.413-414
Add to list
Role of biologics in chronic rhinosinusitis with nasal polyposis : state of the art review

Christine Kim, Joseph Han, Tara Wu, Claus Bachert (UGent) , Wytske Fokkens, Peter Hellings (UGent) , Claire Hopkins, Stella Lee, Joaquim Mullol and Jivianne T. Lee

(2021) OTOLARYNGOLOGY-HEAD AND NECK SURGERY. 164(1). p.57-66
Add to list
- Journal Article
- A1
- open access
Data mining of free-text responses : an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab

Asif H Khan, Adeline Abbe, Bruno Falissard, Paulo Carita, Claus Bachert (UGent) , Joaquim Mullol, Matthew Reaney, Jingdong Chao, Leda P Mannent, Nikhil Amin, et al.

(2021) PATIENT PREFERENCE AND ADHERENCE. 15. p.2577-2586
Add to list
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management

Claus Bachert (UGent) , Joe K. Han, Martin Wagenmann, Werner Hosemann, Stella E. Lee, Vibeke Backer, Joaquim Mullol, Philippe Gevaert (UGent) , Ludger Klimek, Emanuel Prokopakis, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(1). p.29-36

Academic Bibliography

Dupilumab improves health-related quality of life in severe chronic rhinosinusitis with nasal polyps

Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply

Role of biologics in chronic rhinosinusitis with nasal polyposis : state of the art review

Data mining of free-text responses : an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab

EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management

Contents

Support

Contact